Insider Transactions in Q2 2024 at Stoke Therapeutics, Inc. (STOK)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-41.63%
|
$150,000
$15.5 P/Share
|
|
Jun 03
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.47%
|
$0
$0.6 P/Share
|
|
May 20
2024
|
Huw M. Nash Chief Business Officer |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$750,000
$15.39 P/Share
|
|
May 20
2024
|
Huw M. Nash Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$0
$0.4 P/Share
|
|
May 20
2024
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
8,599
-76.8%
|
$128,985
$15.04 P/Share
|
|
May 20
2024
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
8,599
+43.44%
|
$60,193
$7.07 P/Share
|
|
May 20
2024
|
Edward M. Md Kaye CEO |
SELL
Open market or private sale
|
Direct |
42,350
-33.1%
|
$635,250
$15.72 P/Share
|
|
May 01
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-80.1%
|
$110,000
$11.37 P/Share
|
|
May 01
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.47%
|
$0
$0.6 P/Share
|
|
Apr 17
2024
|
Skorpios Trust > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,600,000
-24.92%
|
$39,600,000
$11.6 P/Share
|
|
Apr 01
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,426
-79.14%
|
$122,538
$13.23 P/Share
|
|
Apr 01
2024
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
442
+3.58%
|
$0
$0.6 P/Share
|
|
Apr 01
2024
|
Huw M. Nash Chief Business Officer |
SELL
Open market or private sale
|
Direct |
61,329
-99.67%
|
$797,277
$13.42 P/Share
|
|
Apr 01
2024
|
Huw M. Nash Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+44.91%
|
$0
$0.4 P/Share
|